World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: IRCT
Last refreshed on: 22 February 2018
Main ID:  IRCT201112208104N3
Date of registration: 2012-08-31
Prospective Registration: No
Primary sponsor: Vice Chancellor of Research; Tehran University of Medical Sciences
Public title: Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries
Scientific title: Comparison of oxycodone and naproxen in pain control of soft tissue injuries
Date of first enrolment: 2012-01-01
Target sample size: 150
Recruitment status: Complete
URL:  http://en.irct.ir/trial/8516
Study type:  interventional
Study design:  Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.  
Phase:  2
Countries of recruitment
Iran (Islamic Republic of)
Contacts
Name: Mohammad Amin Zare   
Address:  Emergency Department, Rasoul Akram Hospital, Niyayesh St; Sattarkhan Ave 14456 Tehran Iran (Islamic Republic of)
Telephone: +98 21 6652 5327
Email: mazare74@yahoo.com
Affiliation:  Tehran University of Medical Sciences
Name: Mohammad Amin Zare   
Address:  Emergency Department; Rasoul Akram Hospital, Niyayesh St; Satterkhan Ave 14456 Tehran Iran (Islamic Republic of)
Telephone: +98 21 6652 5327
Email: mazare74@yahoo.com
Affiliation:  Tehran University of Medical Sciences
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criterion: patients above 18 years old with soft tissue injuries. Exclusion criteria: contraindications for opioids and NSAIDs and presence of fracture.
Exclusion criteria:

Age minimum: 18 years
Age maximum: no limit
Gender: Both
Health Condition(s) or Problem(s) studied
musculoskeletal system and connective tissue
soft tissue injuries.
musculoskeletal system and connective tissue
Intervention(s)
Second group receive 10 mg Oxycodone
First group will receive 250 mg Naproxen
Intervention 1: First group will receive 250 mg Naproxen. Intervention 2: Second group receive 10 mg Oxycodone.
Treatment - Drugs
Primary Outcome(s)
Pain control. Timepoint: 0, 30, 60 minutes after treatment. Method of measurement: Numeric Rating Scale.
Secondary Outcome(s)
Presence of side effects. Timepoint: 30 and 60 minutes after treatment. Method of measurement: Patient monitoring.
Need for follow up analgesic. Timepoint: First 24 hours after discharge. Method of measurement: Telephone follow up.
Secondary ID(s)
Source(s) of Monetary Support
Vice Chancellor of Research; Tehran University of Medical Sciences
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Ethics Committee of Tehran University of Medical Sciences
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history